LoginRegister
    HC pulls up Pharma co for violating court orders, directs it to plant 33,000 more saplingsHC pulls up Pharma co for violating court orders, directs it to plant 33,000 more saplings
    Cabinet Nod to Rs 330 crore loan to 3 pharma PSUs for clearing staff liabilitiesCabinet Nod to Rs 330 crore loan to 3 pharma PSUs for clearing staff liabilities
    Abbott hits record high as blood sugar monitoring device- FreeStyle Libre 2 fuels profitAbbott hits record high as blood sugar monitoring device- FreeStyle Libre 2 fuels profit
    Novartis key multiple sclerosis drug Gilenya® approved by China NMPANovartis key multiple sclerosis drug Gilenya® approved by China NMPA
    USFDA completes inspection at Laurus LabsUSFDA completes inspection at Laurus Labs' AP unit
    Sterling Biotech bank fraud case: ED records statements of actor Dino Morea, DJ AqeelSterling Biotech bank fraud case: ED records statements of actor Dino Morea, DJ Aqeel
    DOP rejects Mylan review application for revising retail price of Hepatitis B, HIV drugDOP rejects Mylan review application for revising retail price of Hepatitis B, HIV drug
    Wockhardt new antibiotics under development to have positive impact in future, says founder KhorakiwalaWockhardt new antibiotics under development to have positive impact in future, says founder...
    Over 10 lakh tablets of habit forming painkiller Tramadol seized, Chemist heldOver 10 lakh tablets of habit forming painkiller Tramadol seized, Chemist held
    Patients with NASH have been enrolled in 3 phase III trials of Saroglitazar, says Zydus CadilaPatients with NASH have been enrolled in 3 phase III trials of Saroglitazar, says Zydus Cadila
    Abbott wins USFDA approval for blood plasma screening system Alinity sAbbott wins USFDA approval for blood plasma screening system Alinity s
    Federal data shows opioid shipments ballooned by over 50pc as crisis grewFederal data shows opioid shipments ballooned by over 50pc as crisis grew
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X